🫀 Cardiovascular Update: AI Beats Echo in Amyloidosis, Heartflow Shifts CAD Care, TAVR Shake-Up and More
Get the latest on ground-breaking research, AI breakthroughs, and clinical trials transforming the future of heart health. Whether you’re a clinician, researcher, or life sciences strategist, these insights will keep you on the pulse of the industry.
📌 In This Episode:
🧠 AI detects cardiac amyloidosis with 85 percent sensitivity and 93 percent specificity using echocardiogram video
🧬 New gene mapping tool reveals hidden cardiometabolic disease risks across 45 genetic traits
🫀 Abbott expands valve replacement reach after Boston Scientific’s TAVR market withdrawal
🌿 Biorestorative bypass conduit shows long-term vessel patency without vein harvesting
📈 Philips & Anumana launch ECG AI marketplace to streamline cardiac diagnostics
📊 Heartflow AI changes treatment in over 50 percent of CAD cases, reducing event risk by 15 percent
🔮 AI model predicts valve regurgitation with up to 79 percent accuracy from standard ECGs
🚑 XVIVO begins U.S. heart transport trial with support from CMS and FDA review pathway
💉 Corteria launches heart failure and obesity drug trials with strong GLP-1 synergy
🦵 PoNS device improves stroke-related mobility, triggering FDA breakthrough submission
⚡ Microcurrent therapy improves heart failure outcomes with no serious adverse events
📢 Stay Ahead in Cardiovascular Research!
✅ Like, share, and subscribe for weekly updates on heart failure, AFib, stroke, and more
#Cardiology #HeartHealth #AIinMedicine #CardiovascularResearch #MedicalInnovation #HeartFailure #StrokeRecovery #TAVR #DigitalHealth #LucidQuest #LQVentures #ClinicalTrials #CardiacCare #HealthcareAI